North America Molecular Diagnostics Research Report 2026: An $11.6 Billion Market by 2035, Driven by Innovations in Point-of-care Testing, the Integration of AI, and Companion ...

Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...

Genomics Market to Reach $97.1 Billion by 2033 Globally, at 11.5% CAGR: Allied Market Research

Allied Market Research published a report, titled, "Genomics Market by Product (Consumables and Reagent, Services, Instruments and Systems and Software), Technology (Sequencing, PCR, Flow Cytometry, ...

Proteomics Market Growing at an 11.87% CAGR to 2031 as Precision Medicine & Drug Discovery Adoption Rise, Says a 2026 Mordor Intelligence Report

According to Mordor Intelligence, the proteomics market size was valued at USD 29.92 billion in 2025 and projected to grow from USD 33.47 billion in 2026 to reach USD 58.66 billion by 2031, at a CAGR ...
PharmiWeb

Proteomics Market 2029 | Size, Share. Growth, Analysis and Research Report to Forecast

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...
BioSpace

DNA Microarray Market Size to Grow approximately USD 6.13 Bn by 2034

As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...
ahajournals.org

Prognostic Value of a Multi-mRNA Signature for 1-Year All-Cause Death in Hospitalized Patients With Heart Failure With a Preserved Ejection Fraction

Heart failure with preserved ejection fraction is a major global public health problem, while effective risk stratification tools are still lacking. We sought to construct a multi-mRNA signature to ...
Business Wire

Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification ...